# Effects of TA-65, a Telomerase Activator on Metabolic Syndrome

> **NCT02531334** · NA · COMPLETED · sponsor: **University of Connecticut** · enrollment: 40 (estimated)

## Conditions studied

- Metabolic Syndrome X

## Interventions

- **DIETARY_SUPPLEMENT:** TA-65

## Key facts

- **NCT ID:** NCT02531334
- **Lead sponsor:** University of Connecticut
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531334, "Effects of TA-65, a Telomerase Activator on Metabolic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02531334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*